Reply to: "Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B"
Citation:
Papatheodoridis G, Sypsa V, Lampertico P. Reply to: "Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B". J Hepatol [Internet]. 2021;74:246-247.
National and Kapodistrian University of Athens Medical School, Dept. of Hygiene, Epidemiology and Medical Statistics Building no. 12 M. Asias 75, 11527 Athens, Greece
